AstraZeneca’s CEO Pascal Soriot is warning Western drugmakers to innovate at “Chinese speed” or risk being left behind, likening their current pace to outdated carmakers losing ground to electric vehicle pioneers. While one heart disease drug failed, the company remains bullish, targeting $80 billion in sales by 2030. Soriot also seeks UK government clarity on a US drug pricing deal and sees AI as a productivity booster—not a job killer—in accelerating drug development.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
